Update: On Dec. 20, NYC-DSA's Electoral Working Group voted, 69% to 28%, to recommend endorsing Darializa Avila Chevalier's congressional campaign. The New York City chapter of the Democratic ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Mayor-elect Zohran Mamdani argued that an endorsement of a left-leaning ally, Chi Ossé, would hurt his efforts to secure mainstream Democratic support for his proposals. By Benjamin Oreskes Of all the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Over the last several months, Diana Moreno has spent much of her spare time knocking on doors, asking New Yorkers to vote for her fellow organizer and longtime friend, Zohran Mamdani. And though the ...

The election of Zohran Mamdani as mayor of New York represents a seismic victory for the Democratic Socialists of America. Yet even as the DSA seems poised for a political breakthrough, it shows signs ...

I deeply appreciate the chance to respond to comrade Tom Goodkind’s piece on the DSA and divides in the DSA convention. While I agree with much of the analysis, I would like to very briefly expand on ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...